#235 on the corporate holders of 813 holders
Gilead Sciences, Inc.
10% owner at Arcus Biosciences; 10% owner at Assembly Biosciences; 10% owner at Kyverna Therapeutics.
$640M
in disclosed stock, +$29K (+0.00%) today
Live prices, last trade 3:57 PM ET
- Rank
- 235th of 813
- Companies held
- 6
- Largest holding
- RCUS, 77.4% of total
- Latest SEC filing
- May 26, 2026
What the $640M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arcus Biosciences RCUS Common Stock | Directly | 31,424,760 | $15.77 | $496M | 77.4% | Form 4, Feb 18, 2025 |
| Assembly Biosciences ASMB Common Stock | Directly | 4,977,089 | $22.48 | $112M | 17.5% | Form 4, May 26, 2026 |
| Kyverna Therapeutics KYTX Common Stock | Directly | 4,126,119 | $4.36 | $18.0M | 2.8% | Form 4, Feb 12, 2024 |
| Cypherpunk Technologies CYPH Common Stock | Directly | 5,319,148 | $1.72 | $9.1M | 1.4% | Form 3, Apr 10, 2024 |
| Xilio Therapeutics XLO Common Stock | Directly | 650,389 split-adjusted | $7.61 | $4.9M | 0.8% | Form 4, Dec 18, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Directly | 723,273 split-adjusted | $1.35 | $976K | 0.2% | Form 4, Jun 27, 2023 |
Share counts are the amounts Gilead Sciences, Inc. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 232 | Goldman Sachs Group INC 10% owner, Mirion Technologies | $655M |
| 233 | Tether Global Investments Fund, S.I.C.A.F., S.A. 10% owner, RUM Group | $652M |
| 234 | BCPE Derby (DE) SPV, LP 10% owner, Waystar Holding | $647M |
| 235 | Gilead Sciences, Inc. 10% owner, Arcus Biosciences | $640M |
| 236 | Corsair Group (Cayman), LP 10% owner, Corsair Gaming | $640M |
| 237 | Novo Holdings A/S 10% owner, Edgewise Therapeutics | $637M |
| 238 | WindAcre Partnership Master Fund, LP 10% owner, Perimeter Group | $635M |
Other Arcus Biosciences insiders
All RCUS insiders- Terry J. Rosen$35.3MChief Executive Officer. #3306 overall
- Juan C. Jaen$18.9MPresident. #5433 overall
- Yasunori Kaneko$15.1MDirector. #6417 overall
- Jennifer Jarrett$3.5MChief Operating Officer. #5966 overall
Questions
How much stock does Gilead Sciences, Inc. own?
Gilead Sciences, Inc. holds $640,466,640 in listed stock based on SEC filings and current prices, mostly Arcus Biosciences (RCUS). That ranks 235th on the Stock Rich List.
Is this Gilead Sciences, Inc.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.